Glenmede Trust CO Na Bausch Health Companies Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $47,859 - $66,021	-3,126 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $833 - $1,127	-56 Reduced 1.76%	3,126 $48,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $971 - $1,497	73 Added 2.35%	3,182 $57,000
Q2 2019 Aug 13, 2019	SELL	$20.52 - $26.45 $1,887 - $2,433	-92 Reduced 2.87%	3,109 $77,000
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $3,155 - $4,101	-156 Reduced 4.65%	3,201 $78,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $59,217 - $95,070	3,357 New	3,357 $61,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.94B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.